From Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials
Macrolides, as a class of natural or semisynthetic products, express their antibacterial activity primarily by reversible binding to the bacterial 50S ribosomal subunits and by blocking nascent proteins' progression through their exit tunnel in bacterial protein biosynthesis. Generally consider...
Saved in:
Main Authors: | Dubravko Jelić (Author), Roberto Antolović (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2016-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Randomized Trial of Erythromycin and Azithromycin for Treatment of Chlamydial Infection in Pregnancy
by: Marc F. Rosenn, et al.
Published: (1995) -
The effect of erythromycin and clarithromycin versus azithromycin on serum valproate concentration
by: Muradi Albanji, et al.
Published: (2022) -
Randomized Clinical Trial of Azithromycin vs. Erythromycin for the Treatment of Chlamydia Cervicitis in Pregnancy
by: M. S. Edwards, et al.
Published: (1996) -
Pharmacokinetics of Macrolide Antibiotics and Transport into the Interstitial Fluid: Comparison among Erythromycin, Clarithromycin, and Azithromycin
by: Shinji Kobuchi, et al.
Published: (2020) -
Ribosome Assembly as Antimicrobial Target
by: Rainer Nikolay, et al.
Published: (2016)